There are two versions of the bill now; the original bill proposed capping the price of insulin for everybody who needs it.
Insulet (NASDAQ:PODD – Get Free Report) had its price objective boosted by analysts at Piper Sandler from $285.00 to $310.00 ...
Insulet (NASDAQ:PODD – Get Free Report) had its price target boosted by equities researchers at Citigroup from $310.00 to $355.00 in a note issued to investors on Friday,Benzinga reports. The ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the ...
Eggs are still expensive because of a national shortage. Two experts told us when they think prices could return to normal. Jason Chun is a CNET writer covering a range of topics in tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results